T-Cell-Derived Nanovesicles Functionalized with Anti-PDL1 Antibodies for Oxaliplatin Delivery and Enhanced Antitumor Efficacy in Colorectal Cancer
International Journal of Nanomedicine · 2026-11 · Volume 21 · 1-23
DOI: 10.2147/ijn.s636388 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-11. Verfasst von Ruijie Zhou und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhou, R., Liu, S., Liu, M., Ma, X., Yang, X., Ma, B., Su, C., & Duan, X. (2026). T-Cell-Derived Nanovesicles Functionalized with Anti-PDL1 Antibodies for Oxaliplatin Delivery and Enhanced Antitumor Efficacy in Colorectal Cancer. International Journal of Nanomedicine, Volume 21, 1-23. https://doi.org/10.2147/ijn.s636388
Vancouver
Zhou R, Liu S, Liu M, Ma X, Yang X, Ma B, et al. T-Cell-Derived Nanovesicles Functionalized with Anti-PDL1 Antibodies for Oxaliplatin Delivery and Enhanced Antitumor Efficacy in Colorectal Cancer. International Journal of Nanomedicine. 2026;Volume 21:1-23. doi:10.2147/ijn.s636388
BibTeX
@article{Zhou2026,
author = {Zhou, Ruijie and Liu, Siya and Liu, Miao and Ma, Xinjuan and Yang, Xiaojuan and Ma, Bin and Su, Chunxia and Duan, Xiangguo},
title = {T-Cell-Derived Nanovesicles Functionalized with Anti-PDL1 Antibodies for Oxaliplatin Delivery and Enhanced Antitumor Efficacy in Colorectal Cancer},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--23},
doi = {10.2147/ijn.s636388}
}
EUVIMED